Access the full text.
Sign up today, get DeepDyve free for 14 days.
Yonghong Zhao, L. Gutshall, Haiyan Jiang, Audrey Baker, Eric Beil, G. Obmolova, J. Carton, S. Taudte, B. Amegadzie (2009)
Two routes for production and purification of Fab fragments in biopharmaceutical discovery research: Papain digestion of mAb and transient expression in mammalian cells.Protein expression and purification, 67 2
R. Hintzen, R. Lier, K. Kuijpers, P. Baars, W. Schaasberg, C. Lucas, C. Polman (1991)
Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patientsJournal of Neuroimmunology, 35
A. Yamniuk, A. Suri, S. Krystek, J. Tamura, V. Ramamurthy, R. Kuhn, Karen Carroll, C. Fleener, R. Ryseck, Lin Cheng, Yongmi An, P. Drew, S. Grant, S. Suchard, S. Nadler, J. Bryson, S. Sheriff (2016)
Functional Antagonism of Human CD40 Achieved by Targeting a Unique Species-Specific Epitope.Journal of molecular biology, 428 14
Hyun-Jung An, Young Kim, D. Song, Beom Park, Ho-Min Kim, Ju Lee, S. Paik, Jie-Oh Lee, Hayyoung Lee (2011)
Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation*The Journal of Biological Chemistry, 286
C. Freund, H. Schmalz, J. Sticht, R. Kühne (2008)
Proline-rich sequence recognition domains (PRD): ligands, function and inhibition.Handbook of experimental pharmacology, 186
J. Montfrans, A. Hoepelman, S. Otto, M. Gijn, L. Corput, R. Weger, Linda Monaco-Shawver, P. Banerjee, E. Sanders, C. Zijde, M. Betts, J. Orange, A. Bloem, K. Tesselaar (2012)
CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia.The Journal of allergy and clinical immunology, 129 3
T. Dörner, P. Lipsky (2004)
Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosusLupus, 13
ChangZhen Liu, T. Walter, Peng Huang, Shiqian Zhang, Xuekai Zhu, Ying Wu, L. Wedderburn, P. Tang, R. Owens, D. Stuart, Jingshan Ren, Bin Gao (2010)
Structural and Functional Insights of RANKL–RANK Interaction and SignalingThe Journal of Immunology, 184
K. Tesselaar, Loes Cravestein, M., W. Schijndel, J. Borst (1997)
Characterization of murine CD70, the ligand of the TNF receptor family member CD27.Journal of immunology, 159 10
Julie Denoeud, M. Moser (2011)
Role of CD27/CD70 pathway of activation in immunity and toleranceJournal of Leukocyte Biology, 89
T. Tamada, Daisuke Shinmi, M. Ikeda, Y. Yonezawa, S. Kataoka, R. Kuroki, Eiji Mori, K. Motoki (2015)
TRAIL-R2 Superoligomerization Induced by Human Monoclonal Agonistic Antibody KMTR2Scientific Reports, 5
Hiroyasu Yamamoto, Tadamitsu Kishimoto, Seijiro Minamoto (1998)
NF-kappaB activation in CD27 signaling: involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27.Journal of immunology, 161 9
A. Mccoy, R. Grosse-Kunstleve, P. Adams, M. Winn, L. Storoni, R. Read (2007)
Phaser crystallographic softwareJournal of Applied Crystallography, 40
(2011)
Acta Cryst
O. Alkhairy, R. Perez‐Becker, G. Driessen, Hassan Abolhassani, J. Montfrans, S. Borte, S. Choo, Ning Wang, K. Tesselaar, M. Fang, K. Bienemann, K. Boztug, A. Daneva, F. Mechinaud, T. Wiesel, Christian Becker, G. Dückers, K. Siepermann, M. Zelm, N. Rezaei, M. Burg, A. Aghamohammadi, M. Seidel, T. Niehues, L. Hammarström (2015)
Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency.The Journal of allergy and clinical immunology, 136 3
Harald Wajant (2015)
Principles of antibody-mediated TNF receptor activationCell Death and Differentiation, 22
S. Ito, T. Takayama, H. Hanzawa, K. Ichikawa, J. Ohsumi, N. Serizawa, T. Hata, H. Haruyama (2002)
Crystal structure of the antigen-binding fragment of apoptosis-inducing mouse anti-human Fas monoclonal antibody HFE7A.Journal of biochemistry, 131 1
(2008)
Protein-Protein Interactions as New Drug Targets
F. Makino, J. Ito, Y. Abe, N. Harada, Fumitaka Kamachi, H. Yagita, Kazuhisa Takahashi, K. Okumura, H. Akiba (2012)
Blockade of CD70-CD27 interaction inhibits induction of allergic lung inflammation in mice.American journal of respiratory cell and molecular biology, 47 3
J. Mongkolsapaya, J. Grimes, N. Chen, Xiao-ning Xu, D. Stuart, E. Jones, G. Screaton (1999)
Structure of the TRAIL–DR5 complex reveals mechanisms conferring specificity in apoptotic initiationNature Structural Biology, 6
G. Obmolova, T. Malia, A. Teplyakov, R. Sweet, G. Gilliland (2010)
Promoting crystallization of antibody–antigen complexes via microseed matrix screeningActa Crystallographica Section D: Biological Crystallography, 66
(2016)
Expert Opin
P. Emsley, B. Lohkamp, William Scott, K. Cowtan (2010)
Features and development of CootActa Crystallographica Section D: Biological Crystallography, 66
Bing Li, S. Russell, D. Compaan, K. Totpal, S. Marsters, A. Ashkenazi, A. Cochran, S. Hymowitz, S. Sidhu (2006)
Activation of the proapoptotic death receptor DR5 by oligomeric peptide and antibody agonists.Journal of molecular biology, 361 3
David Camerini, Gerd Walz, W. Loenen, Jannie Borst, Brian Seed (1991)
The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family.Journal of immunology, 147 9
P. Tak, R. Hintzen, J. Teunissen, T. Smeets, M. Daha, R. Lier, P. Kluin, A. Meinders, A. Swaak, F. Breedveld (1996)
Expression of the activation antigen CD27 in rheumatoid arthritis.Clinical immunology and immunopathology, 80 2
A. D'arcy, F. Villard, M. Marsh (2007)
An automated microseed matrix-screening method for protein crystallization.Acta crystallographica. Section D, Biological crystallography, 63 Pt 4
J. Naismith, T. Devine, T. Kohno, S. Sprang (1996)
Structures of the extracellular domain of the type I tumor necrosis factor receptor.Structure, 4 11
M. Nolte, Ronald Olffen, K. Gisbergen, R. Lier (2009)
Timing and tuning of CD27–CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathologyImmunological Reviews, 229
Li-Zhen He, Naseem Prostak, L. Thomas, L. Vitale, Jeffrey Weidlick, Andrea Crocker, Catherine Pilsmaker, Sarah Round, A. Tutt, M. Glennie, H. Marsh, T. Keler (2013)
Agonist Anti-Human CD27 Monoclonal Antibody Induces T Cell Activation and Tumor Immunity in Human CD27–Transgenic MiceThe Journal of Immunology, 191
Agnes Wyzgol, N. Müller, A. Fick, Sabine Munkel, G. Grigoleit, K. Pfizenmaier, H. Wajant (2009)
Trimer Stabilization, Oligomerization, and Antibody-Mediated Cell Surface Immobilization Improve the Activity of Soluble Trimers of CD27L, CD40L, 41BBL, and Glucocorticoid-Induced TNF Receptor Ligand1The Journal of Immunology, 183
F. Chan, H. Chun, Lixin Zheng, R. Siegel, Kimmie Bui, M. Lenardo (2000)
A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling.Science, 288 5475
M. Chodorge, S. Züger, C. Stirnimann, C. Briand, L. Jermutus, M. Grütter, R. Minter (2012)
A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potencyCell Death and Differentiation, 19
J. Graves, J. Kordich, Tzu-Hsuan Huang, J. Piasecki, T. Bush, T. Sullivan, I. Foltz, Wesley Chang, Heather Douangpanya, Thu Dang, J. O'neill, R. Mallari, Xiaoning Zhao, D. Branstetter, J. Rossi, A. Long, Xin Huang, P. Holland (2014)
Apo2L/TRAIL and the death receptor 5 agonist antibody AMG 655 cooperate to promote receptor clustering and antitumor activity.Cancer cell, 26 2
M. Winn, C. Ballard, K. Cowtan, E. Dodson, P. Emsley, P. Evans, R. Keegan, E. Krissinel, A. Leslie, A. Mccoy, S. McNicholas, G. Murshudov, N. Pannu, E. Potterton, H. Powell, R. Read, A. Vagin, K. Wilson (2011)
Overview of the CCP4 suite and current developmentsActa Crystallographica Section D: Biological Crystallography, 67
(2015)
Cell Death Differ
G. Obmolova, A. Teplyakov, T. Malia, Nicole Wunderler, D. Kwok, L. Barone, R. Sweet, T. Ort, Michael Scully, G. Gilliland (2017)
Epitope‐dependent mechanisms of CD27 neutralization revealed by X‐ray crystallographyMolecular Immunology, 83
J. Naismith, S. Sprang (1998)
Modularity in the TNF-receptor family.Trends in biochemical sciences, 23 2
Frederic Fellouse, Bing Li, D. Compaan, A. Peden, S. Hymowitz, S. Sidhu (2005)
Molecular recognition by a binary code.Journal of molecular biology, 348 5
J. Borst, J. Hendriks, Yanling Xiao (2005)
CD27 and CD70 in T cell and B cell activation.Current opinion in immunology, 17 3
D. Banner, A. D'arcy, W. Janes, R. Gentz, H. Schoenfeld, C. Broger, H. Loetscher, W. Lesslauer (1993)
Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activationCell, 73
C. Adams, K. Totpal, David Lawrence, S. Marsters, R. Pitti, S. Yee, S. Ross, L. Deforge, H. Koeppen, M. Sagolla, D. Compaan, H. Lowman, S. Hymowitz, A. Ashkenazi (2008)
Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5Cell Death and Differentiation, 15
R. Laskowski, M. MacArthur, D. Moss, J. Thornton (1993)
PROCHECK: a program to check the stereochemical quality of protein structuresJournal of Applied Crystallography, 26
M. Macias, S. Wiesner, M. Sudol (2002)
WW and SH3 domains, two different scaffolds to recognize proline‐rich ligandsFEBS Letters, 513
H. Wajant (2016)
Therapeutic targeting of CD70 and CD27Expert Opinion on Therapeutic Targets, 20
J. Hendriks, L. Gravestein, K. Tesselaar, R. Lier, T. Schumacher, J. Borst (2000)
CD27 is required for generation and long-term maintenance of T cell immunityNature Immunology, 1
CD27 is a T‐cell and B‐cell co‐stimulatory glycoprotein of the tumor necrosis factor (TNF) receptor superfamily that is dependent on the availability of the TNF‐like ligand CD70. Therapeutic approaches to treating autoimmune diseases and cancers with antagonistic and agonistic anti‐CD27 monoclonal antibodies (mAbs), respectively, have recently been developed. Mouse anti‐human CD27 mAb 2177 shows potency in neutralizing CD70‐induced signaling; however, it does not block the binding of soluble CD70. To provide insight into the mechanism of action of the mAb, the crystal structure of the CD27 extracellular domain in complex with the Fab fragment of mAb 2177 was determined at 1.8 Å resolution. CD27 exhibits the assembly of cysteine‐rich domains characteristic of the TNF receptor superfamily. The structure reveals a unique binding site of mAb 2177 at the edge of the receptor molecule, which allows the mAb to sterically block the cell‐bound form of CD70 from reaching CD27 while leaving the ligand epitope clear. This mode of action suggests a potential dual use of mAb 2177 either as an antagonist or as an agonist.
Acta Crystallographica Section F – Wiley
Published: Jan 1, 2017
Keywords: ; ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.